Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.76 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NAMPT | P43490 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CASP2 | P42575 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1846096 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL10937726 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL14739632 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL6516953 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL14740196 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL14739904 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL1900654 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL1847535 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL14740132 | 1.00 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL860791 | 0.97 | KDM4E (0.94) | KDM4EMAPK1HIF1APAOXADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9631 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20250205310-A1 | METHOD FOR REVERSING BODY-WIDE AGE-ASSOCIATED FUNCTIONAL CHANGES | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-06-26 | — | — | US | claimed |
| CN-119361799-A | Diaphragm coated MOFs glass in-situ polymerization solid electrolyte and preparation method and application thereof | 辽宁科技大学 | 2025-01-24 | — | — | CN | claimed |
| CN-119339984-A | Metal-organic framework glass material for solidifying radionuclides and preparation method thereof | 辽宁科技大学 | 2025-01-21 | — | — | CN | claimed |
| CN-119297419-A | Air stable glassy metal-organic framework electrolyte material and preparation method thereof | 辽宁科技大学 | 2025-01-10 | — | — | CN | claimed |
| US-20240343697-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2024-10-17 | — | — | US | claimed |
| CN-117996002-A | Preparation method and application of sodium metal negative electrode modified by artificial solid electrolyte interface layer | 河南易成新能源股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117747793-A | Method for preparing surface-modified layered oxide by low-temperature solid-liquid reaction and application thereof | 郑州轻工业大学 | 2024-03-22 | — | — | CN | claimed |
| EP-2796112-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2023-08-09 | — | — | EP | claimed |
| EP-0359347-A2 | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging | NEORX CORPORATION (US) | 1990-03-21 | — | — | EP | claimed |
| EP-0043853-B1 | INJECTION MOLDABLE AMIDE-IMIDE POLYMERS CONTAINING DIVALENT ALIPHATIC RADICALS DERIVED FROM ALIPHATIC DIAMINES | AMOCO CORPORATION (US) | 1985-11-13 | — | — | EP | claimed |
| EP-0043853-A4 | INJECTION MOLDABLE AMIDE-IMIDE POLYMERS CONTAINING DIVALENT ALIPHATIC RADICALS DERIVED FROM ALIPHATIC DIAMINES. | STANDARD OIL CO (US) | 1982-05-28 | — | — | EP | claimed |
| US-4323493-A | Injection moldable amide-imide polymers contaning divalent aliphatic radicals derived from aliphatic diamines | STANDARD OIL COMPANY (INDIANA) (US) | 1982-04-06 | — | — | US | claimed |
| US-4321357-A | Injection moldable amide-imide polymers containing divalent aliphatic radicals derived from aliphatic diamines | STANDARD OIL COMPANY (INDIANA) (US) | 1982-03-23 | — | — | US | claimed |
| EP-0043853-A1 | INJECTION MOLDABLE AMIDE-IMIDE POLYMERS CONTAINING DIVALENT ALIPHATIC RADICALS DERIVED FROM ALIPHATIC DIAMINES. | STANDARD OIL CO (US) | 1982-01-20 | — | — | EP | claimed |
| EP-0005476-B1 | PROCESS FOR PREPARING HUMAN INTERFERON | Dr. Karl Thomae GmbH (DE) | 1981-12-30 | — | — | EP | claimed |
| WO-1981002015-A1 | INJECTION MOLDABLE AMIDE-IMIDE POLYMERS CONTAINING DIVALENT ALIPHATIC RADICALS DERIVED FROM ALIPHATIC DIAMINES | STANDARD OIL CO (US) | 1981-07-23 | — | — | WO | claimed |
| US-4266024-A | USING ALKYLENEDIAMIDES, DIMETHYL SULFOXIDE OR GLUCOCORTICOIDS AS STIMULATORS FOR LYMPHOID CELLS | BOEHRINGER INGELHEIM GMBH (DE) | 1981-05-05 | — | — | US | claimed |
| EP-0005476-A2 | Process for preparing human interferon | Dr. Karl Thomae GmbH (DE) | 1979-11-28 | — | — | EP | claimed |